Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma.

Luther GA, Lamplot J, Chen X, Rames R, Wagner ER, Liu X, Parekh A, Huang E, Kim SH, Shen J, Haydon RC, He TC, Luu HH.

Cancer Lett. 2013 Aug 9;336(1):222-30. doi: 10.1016/j.canlet.2013.05.002. Epub 2013 May 9.

2.

Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.

Su Y, Wagner ER, Luo Q, Huang J, Chen L, He BC, Zuo GW, Shi Q, Zhang BQ, Zhu G, Bi Y, Luo J, Luo X, Kim SH, Shen J, Rastegar F, Huang E, Gao Y, Gao JL, Yang K, Wietholt C, Li M, Qin J, Haydon RC, He TC, Luu HH.

Oncogene. 2011 Sep 15;30(37):3907-17. doi: 10.1038/onc.2011.97. Epub 2011 Apr 4.

PMID:
21460855
3.

PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.

Onishi Y, Kawamoto T, Kishimoto K, Hara H, Fukase N, Toda M, Harada R, Kurosaka M, Akisue T.

Int J Oncol. 2012 Jun;40(6):1839-48. doi: 10.3892/ijo.2012.1400. Epub 2012 Mar 12.

PMID:
22426824
4.

Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.

Ren L, Mendoza A, Zhu J, Briggs JW, Halsey C, Hong ES, Burkett SS, Morrow J, Lizardo MM, Osborne T, Li SQ, Luu HH, Meltzer P, Khanna C.

Oncotarget. 2015 Oct 6;6(30):29469-81. doi: 10.18632/oncotarget.5177.

5.
6.

IGF-1 receptor contributes to the malignant phenotype in human and canine osteosarcoma.

MacEwen EG, Pastor J, Kutzke J, Tsan R, Kurzman ID, Thamm DH, Wilson M, Radinsky R.

J Cell Biochem. 2004 May 1;92(1):77-91.

PMID:
15095405
7.

STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.

Tu B, Du L, Fan QM, Tang Z, Tang TT.

Cancer Lett. 2012 Dec 1;325(1):80-8. doi: 10.1016/j.canlet.2012.06.006. Epub 2012 Jun 26.

PMID:
22743617
8.

Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.

Miao JH, Wang SQ, Zhang MH, Yu FB, Zhang L, Yu ZX, Kuang Y.

Oncol Rep. 2014 Oct;32(4):1497-504. doi: 10.3892/or.2014.3358. Epub 2014 Jul 24.

PMID:
25069486
9.

Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.

Endo-Munoz L, Cai N, Cumming A, Macklin R, Merida de Long L, Topkas E, Mukhopadhyay P, Hill M, Saunders NA.

PLoS One. 2015 Aug 28;10(8):e0133592. doi: 10.1371/journal.pone.0133592. eCollection 2015.

10.

Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.

Di Fiore R, Drago-Ferrante R, Pentimalli F, Di Marzo D, Forte IM, Carlisi D, De Blasio A, Tesoriere G, Giordano A, Vento R.

J Cell Physiol. 2016 Aug;231(8):1832-41. doi: 10.1002/jcp.25291. Epub 2016 Jan 28.

PMID:
26679758
11.

Deguelin inhibits the migration and invasion of U-2 OS human osteosarcoma cells via the inhibition of matrix metalloproteinase-2/-9 in vitro.

Shang HS, Chang JB, Lin JH, Lin JP, Hsu SC, Liu CM, Liu JY, Wu PP, Lu HF, Au MK, Chung JG.

Molecules. 2014 Oct 15;19(10):16588-608. doi: 10.3390/molecules191016588.

12.

RNAi-mediated silencing of AQP1 expression inhibited the proliferation, invasion and tumorigenesis of osteosarcoma cells.

Wu Z, Li S, Liu J, Shi Y, Wang J, Chen D, Luo L, Qian Y, Huang X, Wang H.

Cancer Biol Ther. 2015;16(9):1332-40. doi: 10.1080/15384047.2015.1070983. Epub 2015 Jul 15.

13.

MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.

Shi Y, Huang J, Zhou J, Liu Y, Fu X, Li Y, Yin G, Wen J.

Oncol Rep. 2015 Jul;34(1):399-406. doi: 10.3892/or.2015.3986. Epub 2015 May 19.

PMID:
25998694
14.

Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.

Jaroensong T, Endo Y, Lee SJ, Kamida A, Mochizuki M, Nishimura R, Sasaki N, Nakagawa T.

Vet Comp Oncol. 2012 Dec;10(4):274-82. doi: 10.1111/j.1476-5829.2011.00294.x. Epub 2011 Sep 9.

PMID:
22236104
15.

Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.

Yu W, Zhang Z, Min D, Yang Q, Du X, Tang L, Lin F, Sun Y, Zhao H, Zheng S, He A, Li H, Yao Y, Shen Z.

Eur J Cancer. 2014 Apr;50(6):1125-36. doi: 10.1016/j.ejca.2014.01.030. Epub 2014 Feb 21.

PMID:
24565852
16.

Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.

Zhang CL, Wang C, Yan WJ, Gao R, Li YH, Zhou XH.

Oncol Rep. 2014 Sep;32(3):1149-55. doi: 10.3892/or.2014.3291. Epub 2014 Jun 25.

PMID:
24969828
17.

miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.

Zhao H, Ma B, Wang Y, Han T, Zheng L, Sun C, Liu T, Zhang Y, Qiu X, Fan Q.

Oncol Rep. 2013 Mar;29(3):1027-36. doi: 10.3892/or.2013.2234. Epub 2013 Jan 11.

PMID:
23314380
18.

RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.

Zhou XH, Yang CQ, Zhang CL, Gao Y, Yuan HB, Wang C.

Oncol Rep. 2014 Oct;32(4):1505-12. doi: 10.3892/or.2014.3387. Epub 2014 Aug 7.

PMID:
25109282
19.

Dominant negative LRP5 decreases tumorigenicity and metastasis of osteosarcoma in an animal model.

Guo Y, Rubin EM, Xie J, Zi X, Hoang BH.

Clin Orthop Relat Res. 2008 Sep;466(9):2039-45. doi: 10.1007/s11999-008-0344-y. Epub 2008 Jun 20.

20.

NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma.

Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, Jones SN, Lazar AJ, Ingram D, Lev D, Donehower LA, Yustein JT.

Oncogene. 2015 Sep 24;34(39):5069-79. doi: 10.1038/onc.2014.429. Epub 2015 Jan 12.

Supplemental Content

Support Center